Yesterday, a Director at AbbVie (ABBV), Edward Rapp, bought shares of ABBV for $252.6K.
Following this transaction Edward Rapp’s holding in the company was increased by 100% to a total of $263.8K. Following Edward Rapp’s last ABBV Buy transaction on June 28, 2019, the stock climbed by 22.1%.
See today’s analyst top recommended stocks >>
Based on AbbVie’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $8.7 billion and quarterly net profit of $2.79 billion. In comparison, last year the company earned revenue of $8.31 billion and had a GAAP net loss of $1.82 billion. The company has a one-year high of $97.86 and a one-year low of $62.66. Currently, AbbVie has an average volume of 10.17M.
Four different firms, including Cowen & Co. and Mizuho Securities, currently also have a Buy rating on the stock.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABBV:
